- Home
- CEPU vs NEO Comparison
CEPU vs NEO Comparison
Compare CEPU & NEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CEPU
- NEO
- Stock Information
- Founded
- CEPU 1989
- NEO 2001
- Country
- CEPU Argentina
- NEO United States
- Employees
- CEPU N/A
- NEO N/A
- Industry
- CEPU Electric Utilities: Central
- NEO Precision Instruments
- Sector
- CEPU Utilities
- NEO Health Care
- Exchange
- CEPU Nasdaq
- NEO Nasdaq
- Market Cap
- CEPU 1.4B
- NEO 1.2B
- IPO Year
- CEPU 2018
- NEO 1999
- Fundamental
- Price
- CEPU $15.87
- NEO $10.13
- Analyst Decision
- CEPU Strong Buy
- NEO Buy
- Analyst Count
- CEPU 1
- NEO 10
- Target Price
- CEPU $17.50
- NEO $12.56
- AVG Volume (30 Days)
- CEPU 656.2K
- NEO 5.0M
- Earning Date
- CEPU 11-12-2025
- NEO 10-28-2025
- Dividend Yield
- CEPU 1.95%
- NEO N/A
- EPS Growth
- CEPU N/A
- NEO N/A
- EPS
- CEPU 0.12
- NEO N/A
- Revenue
- CEPU $628,806,380.00
- NEO $709,162,000.00
- Revenue This Year
- CEPU $11.09
- NEO $10.74
- Revenue Next Year
- CEPU $10.25
- NEO $9.85
- P/E Ratio
- CEPU $16.87
- NEO N/A
- Revenue Growth
- CEPU N/A
- NEO 10.10
- 52 Week Low
- CEPU $7.43
- NEO $4.72
- 52 Week High
- CEPU $16.60
- NEO $19.12
- Technical
- Relative Strength Index (RSI)
- CEPU 77.45
- NEO 57.58
- Support Level
- CEPU $13.66
- NEO $9.42
- Resistance Level
- CEPU $16.54
- NEO $10.58
- Average True Range (ATR)
- CEPU 0.91
- NEO 0.56
- MACD
- CEPU 0.72
- NEO -0.12
- Stochastic Oscillator
- CEPU 91.59
- NEO 32.90
About CEPU Central Puerto S.A. (each represents ten)
Central Puerto SA is a power generation company. It is mainly engaged in electric power generation and commercialization. The company is also involved in the natural gas distribution public sector service in the Cuyo and Centro regions in Argentina. The Group has four reporting segments which includes electric power generation from conventional sources, electric power generation from renewable sources, natural gas transport and distribution, and forest activity.. The company derives maximum revenue from Electric Power Generation from conventional sources segment.
About NEO NeoGenomics Inc.
NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. It operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.